Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations(2 sites)
United States
Brigham and Women's Hospital, Boston, Massachusetts Dana-Farber Cancer Institute, Boston, Massachusetts Last updated January 2026